Engineered Matrix to Improve T Cell Immunotherapy
Researchers from Johns Hopkins University have developed an “artificial lymph node” to help multiply antigen-specific T cells to fight cancer. They used a hydrogel that contains immunostimulatory antigen-presenting nanoparticles to encourage T ce...
Source: Medgadget - Category: Medical Devices Authors: Siavash Parkhideh Tags: Genetics Materials Medicine Oncology Source Type: blogs
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Chemistry | Environmental Health | Genetics | Immunotherapy | John Hopkins University | Medical Devices | Melanoma | Nanotechnology | Pathology | Skin Cancer | Study